Tislelizumab/Zanubrutinib Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of tislelizumab and zanubrutinib that may be used in the treatment of chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

**Synonyms:** - Tevimbra/Brukinsa - Tislelizumab Plus Zanubrutinib - Tislelizumab-Zanubrutinib - Tislelizumab-jsgr/Zanubrutinib - Tislelizumab/Zanubrutinib - Zanubrutinib/Tislelizumab